Discontinued — last reported Q4 '11
Merck & Co. Buildings and improvements increased by 9.9% to $17.98B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.9%, from $16.36B to $17.98B. Over 5 years (FY 2020 to FY 2025), Buildings and improvements shows an upward trend with a 7.3% CAGR.
An increase indicates capital investment in infrastructure, while a decrease reflects depreciation or the disposal of facilities.
This includes the cost of all physical structures, such as manufacturing plants, research centers, and office buildings,...
High-capital-intensive industries like pharma require significant investment in specialized facilities compared to service-based sectors.
ppe_buildings| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $12.53B | $13.17B | $14.97B | $16.36B | $17.98B |
| QoQ Change | — | +5.1% | +13.7% | +9.3% | +9.9% |
| YoY Change | — | +5.1% | +13.7% | +9.3% | +9.9% |
| % of PP&E (Net) | 65.0% | 61.5% | 64.9% | 68.8% | 71.0% |
| Share Change | — | -3.5pp | +3.5pp | +3.9pp | +2.2pp |
We use cookies for analytics. See our Privacy and Cookie Policy.